Richtlijn Guillain-Barré syndroom

KlimetrieHolman R, Lindeboom R, Vermeulen M, de Haan RJ. The AMC Linear Disability Score projectin a population requiring residential care: psychometric properties. Health Qual Life Outcomes2004;2:42.Holman R, Weisscher N, Glas CA, et al. The Academic Medical Center Linear Disability Score(ALDS) item bank: item response theory analysis in a mixed patient population. Health Qual LifeOutcomes 2005;3:83.Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment ofmuscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve1991;14(11):1103-9.Lunn MP, Léger JM, Merkies IS, Van den Bergh P, van Schaik IN; Inflammatory NeuropathyConsortium; ENMC. 151st ENMC international workshop: Inflammatory Neuropathy Consortium13th-15th April 2007, Schiphol, The Netherlands. Neuromuscul Disord 2008;18(1):85-9.Martina, I.S.J., van Koningsveld R, Schmitz P.I.M., van der Meche F.G.A., van Doorn P.A. forthe Inflammatory Neuropathy Cause and Treatment (INCAT) Group J Neurol NeurosurgPsychiatry 1998;65:743-747.Merkies IS, Schmitz PI, Samijn JP, van der Meché FG, van Doorn PA. Fatigue in immunemediatedpolyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT)Group. Neurology 1999;53(8):1648-54.Merkies IS, Schmitz PI, Samijn JP, Meche FG, Toyka KV, Van Doorn PA, et al. Assessing gripstrength in healthy individuals and patients with immune-mediated polyneuropathies. MuscleNerve 2000; 23(9):1393-1401. [a]Merkies ISJ, Schmitz PIM, Van Der Meche FG, Van Doorn PA. Psychometric evaluation of anew sensory scale in immune-mediated polyneuropathies. Neurology 2000;54(4):943-949. [b]Merkies ISJ, Schmitz PIM, Van Der Meche FG, Van Doorn PA. Reliability and responsivenessof a graduated tuning fork in immune mediated polyneuropathies. J Neurol NeurosurgPsychiatry 2000;68:669-67. [c]Merkies IS, Schmitz PI, Van Der Meche FG, Samijn JP, Van Doorn PA. InflammatoryNeuropathy Cause and Treatment (INCAT) Group., et al. Clinimetric evaluation of a new overalldisability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72(5):596-601. [a]Merkies ISJ, Schmitz PIM, Van Der Meche FG, Samijn JP, Van Doorn PA. Psychometricevaluation of a new handicap scale in immune-mediated polyneuropathies. Muscle Nerve 2002;25:370-377. [b]Merkies IS, Schmitz PI, Van Der Meche FG, Samijn JP, Van Doorn PA. InflammatoryNeuropathy Cause and Treatment (INCAT) Group., et al. Quality of life complements traditionaloutcome measures in immune-mediated polyneuropathies. Neurology 2002;59(1):84-91. [c]198